Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma☆
Titel:
Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma☆
Auteur:
Lian, B. Li, Z. Wu, N. Li, M. Chen, X. Zheng, H. Gao, M. Wang, D. Sheng, X. Tian, H. Si, L. Chi, Z. Wang, X. Lai, Y. Sun, T. Zhang, Q. Kong, Y. Long, G.V. Guo, J. Cui, C.